Adrian Rabin
Lawyers
Filters
Stoke Therapeutics $125 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Select Market
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
MSCI acquisition of Fabric RQ
We are advising MSCI on the acquisition
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Sealed Air $425 million senior notes offering and concurrent tender offer
The new high-yield notes are due 2031
Newfold Digital Holdings Group $515 million senior secured notes offering
The high-yield notes are due 2028
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction